What do you need to be fundable in 2024?

Medicon Village Academy hosted by Syneos Health®

With the evolving landscape and investor outlook and the challenges of developing new technologies and assets in the current biotech environment, this is an insightful and in-depth roundtable discussion with Syneos Health® and one of their strategic partners, TreeHill Partners, focusing on the key areas which should be considered by biotech companies to ensure they give themselves the best chance of success with potential investors and in terms of their asset development and corporate goals in 2024 and beyond.

Syneos Health® and Medicon Village welcome you to an engaging afternoon.

Programme

12:00-12:45 Lunch and networking

12:45-13:15 Welcome and Introduction to:

• Syneos Health®, Bharat Chudasama Vice President, Strategic Enterprise Partnerships, Europe
• TreeHill Partners, Mark Mayhew, PhD, Head of Portfolio and Strategy

13:15-14:15 Round table discussion 1: The do’s and don’ts to be fundable in 2024 and beyond

• Mark Mayhew, Partner, Treehill Partners
• Bharat Chudasama Vice President, Strategic Enterprise Partnerships, Europe, Syneos Health®

14:15-14:45 Networking Break #1

14:45-16:00 Round table discussion 2: How can Syneos Health better support growing R&D Biotech Companies navigate the current environment?

• Bharat Chudasama Vice President, Strategic Enterprise Partnerships, Europe Syneos Health®
• Paul Holmes, MD, EU Consulting, Syneos Health®
• Chris Ponty, VP, One Asset Development Lead Syneos Health®

 16:00-16:45 Networking Break #2 (Canapes & Drinks)



About Syneos Health®

Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.